vitamin
may
protect
acut
respiratori
infect
atop
ill
studi
conflict
one
like
reason
vast
variabl
measur
vitamin
base
interview
dietari
intak
vs
actual
measur
concentr
major
differ
studi
popul
age
confirm
atopi
statu
use
vitamin
supplement
latitud
studi
region
recommend
minimum
level
serum
vari
nmoll
finland
young
children
instruct
vitamin
supplement
iu
per
day
despit
recommend
level
serum
defici
nmoll
finnish
children
western
popul
children
report
level
nmoll
howev
data
remain
scarc
level
children
suscept
viral
infect
asthma
develop
young
wheez
children
investig
issu
analyz
serum
level
cohort
wheez
children
well
character
viru
etiolog
atopi
statu
serum
sampl
nasopharyng
aspir
collect
wheez
children
turku
univers
hospit
turku
finland
june
march
children
particip
random
control
trial
studi
effect
oral
corticosteroid
inclus
criteria
consist
age
month
deliveri
gestat
week
first
wheezi
episod
parent
report
confirm
medic
record
written
inform
consent
parent
guardian
exclus
criteria
consist
chronic
ill
previou
system
inhal
corticosteroid
treatment
need
intens
care
unit
treatment
studi
commenc
obtain
written
inform
consent
parent
studi
protocol
approv
ethic
committe
turku
univers
hospit
studi
entri
guardian
ask
fill
standard
health
questionnair
onlin
supplementari
child
physic
examin
studi
physician
nasopharyng
aspir
sampl
obtain
viral
diagnost
use
standard
procedur
baselin
blood
sampl
drawn
wheez
refer
expiratori
breath
difficulti
high
pitch
sound
expir
eczema
defin
atop
eczema
ige
sensit
present
need
hospit
decid
physician
outsid
studi
team
ill
sever
score
sum
score
degre
dyspnea
none
mild
moder
sever
type
breath
normal
use
stomach
muscl
use
intercost
muscl
nasal
flare
sever
auscultatori
find
none
expiratori
inspiratori
expiratori
audibl
without
stethoscop
assess
expiratori
inspiratori
time
children
discharg
hospit
respiratori
symptom
score
wheez
parent
fill
diari
respiratori
symptom
cough
breath
difficulti
noisi
breath
symptom
sleep
use
bronchodil
week
hospit
discharg
see
detail
onlin
supplementari
serum
measur
taken
liquid
mass
spectrometri
massachusett
gener
hospit
boston
usa
blood
eosinophil
count
serum
level
ige
common
allergen
kul
phadiatop
phadia
uppsala
sweden
analyz
routin
diagnost
central
laboratori
turku
univers
hospit
rhinoviru
speci
b
c
enterovirus
respiratori
syncyti
viru
rsv
b
detect
within
day
refriger
nasopharyng
aspir
use
hous
pcr
viru
diagnost
laboratori
depart
virolog
univers
turku
addit
multiplex
pcr
test
seeplex
ace
detect
seegen
seoul
korea
use
detect
rhinoviru
b
adenoviru
coronaviru
human
metapneumoviru
influenza
b
viru
parainfluenza
viru
type
rsv
b
viru
storag
human
analyz
use
pcr
serolog
previous
describ
analyz
viru
load
ie
copi
number
steril
flock
swab
catalog
number
copan
brescia
itali
first
dip
aspir
dilut
ml
salin
basic
statist
analys
two
sampl
anova
spearman
correl
regress
analysi
use
analyz
associ
concentr
differ
variabl
multivari
linear
regress
analysi
use
analys
rhinoviru
load
analysi
parametr
variabl
express
mean
standard
deviat
sd
nonparametr
variabl
median
interquartil
rang
iqr
linear
regress
result
express
mean
differ
confid
interv
ci
p
consid
statist
signific
analys
perform
use
sa
enterpris
guid
sa
institut
cari
nc
usa
children
elig
studi
declin
particip
exclus
anoth
six
patient
lack
vitamin
measur
children
includ
analyt
cohort
fig
mean
age
month
sd
boy
children
atopi
anoth
characterist
ie
sensit
blood
eosinophil
count
atop
eczema
least
one
viru
detect
sampl
rhinoviru
children
respiratori
syncyti
viru
bocaviru
children
seventeen
children
serodiagnos
acut
bocaviru
infect
bocaviru
found
children
viru
coinfect
detect
children
mean
concentr
nmoll
sd
rang
five
children
serum
concentr
nmoll
nmoll
serum
level
nmoll
higher
detect
children
tabl
tabl
unadjust
analysi
serum
concentr
invers
associ
age
p
femal
sex
p
bocaviru
etiolog
p
blood
eosinophil
count
p
sensit
atop
eczema
rhinoviru
etiolog
rsv
etiolog
p
analysi
concentr
invers
associ
femal
sex
atop
characterist
viru
etiolog
atop
characterist
modifi
associ
concentr
viru
etiolog
associ
found
hospit
admiss
season
recruit
indoor
pet
famili
histori
asthma
viru
coinfect
ill
sever
includ
ill
durat
admiss
hospit
heart
rate
blood
oxygen
satur
temperatur
ill
sever
score
studi
entri
durat
hospit
durat
respiratori
symptom
within
week
discharg
tabl
tabl
studi
age
major
determin
concentr
wheez
children
despit
particip
famili
visit
n
report
given
vitamin
supplement
earli
life
strong
invers
associ
seen
studi
well
earlier
studi
specul
supplement
use
becom
irregular
earli
childhood
contrari
incid
atop
sensit
increas
age
one
might
expect
associ
atopi
atop
characterist
kind
circumst
find
analysi
recent
studi
stenberg
et
al
report
associ
vitamin
insuffici
wheez
young
children
find
associ
vitamin
statu
factor
studi
young
children
without
wheez
older
children
report
invers
associ
level
atop
dermat
sever
atop
dermat
differ
find
studi
may
explain
adequ
mean
concentr
studi
popul
nmoll
studi
mean
level
serum
much
lower
studi
exampl
nmoll
nmoll
besid
atopi
low
concentr
report
associ
increas
suscept
acut
respiratori
infect
find
connect
specif
respiratori
viru
infect
even
sensit
marker
rhinoviru
load
viru
coinfect
prolong
shed
bocaviru
base
combin
pcr
serolog
diagnost
wheez
children
urashima
et
al
studi
effect
vitamin
intak
suscept
influenza
infect
japanes
school
children
report
invers
effect
howev
measur
serum
level
studi
scienc
et
al
report
low
serum
level
associ
increas
risk
acut
respiratori
infect
compar
studi
median
level
serum
lower
studi
nmoll
may
explain
signific
associ
studi
limit
sampl
size
rather
small
moreov
children
level
nmoll
vitamin
defici
could
investig
result
may
applic
children
countri
finnish
children
instruct
take
daili
vitamin
supplement
although
intak
vitamin
supplement
close
record
assess
best
measur
vitamin
statu
serum
level
conclus
wheez
children
receiv
vitamin
supplement
iu
per
day
mean
level
nmoll
iqr
nmoll
level
associ
rhinoviru
rsv
bocaviru
infect
viru
coinfect
atopi
sever
ill
result
gener
hypothesi
serum
level
thought
adequ
healthi
children
suffici
also
children
suscept
asthma
relat
paper
author
conflict
interest
